Top Markets
#1 Derive Derive +30.84%
#2 Cross Cross +17.10%
#3 Audiera Audiera +15.13%
#4 Humanity Humanity +10.96%
#5 Cap Cap +10.49%
#6 Velvet Velvet +10.37%
#7 The Bitcoin Bull The Bitcoin Bull +10.22%
#8 Geodnet Geodnet +8.81%
#9 Based Based +8.66%
#10 Biconomy Biconomy +7.67%
Coin of the day
Derive Derive
Settings
Language
ENGLISH
Currency
USD
Theme
Panjon Ltd. Panjon Ltd.

Panjon Ltd.

PANJON
Rank in Stocks #35644
Panjon Ltd. specializes in the production and commercialization of both... Panjon Ltd. specializes in the production and commercialization of both conventional (allopathic) and traditional (Ayurvedic) pharmaceutical goods. Its extensive product line encompasses tablets, balms, inhalers, and cough remedies, alongside its well-known Swad and Swad Chatpati digestive candies. Established in 1964 by Nagin Bhai Kothari, the firm's main operations are directed from its headquarters in Indore, India.
Share Price
$0.2106749
Last synced: 2026-08-14
Market Cap
$3.62M
Change (1 day)
-2.25%
Change (1 year)
2.92%
Country
IN
Trade Panjon Ltd. (PANJON)

Category

Healthcare
Revenue for Panjon Ltd. (PANJON)
Revenue in Aug 2026 TTM: 0
According to Panjon Ltd. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Panjon Ltd. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
 $2.54B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
 - -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
 - -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
 - -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
 $830.81M -
US